Reproductive Health

ExEm Foam, the Only FDA-Approved Contrast Agent for Ultrasound Tubal Patency Testing Is Now Available in the U.S.

ExEm Foam Inc announced today that ExEm Foam (air polymer-type A intrauterine foam), the only FDA-approved contrast agent for ultrasound tubal patency testing, is now available at select fertility clinics in the U.S.. The Foam procedure, a new ultrasound technique of hysterosalpingo foam sonography (HyFoSy), uses ExEm Foam to assess whether there may be a blockage in the fallopian tubes in women…

Ferring, Rebiotix and MyBiotics Collaborate to Develop Live Microbiome-Based Therapeutics in Reproductive Medicine and Maternal Health

Ferring Pharmaceuticals, Rebiotix, a Ferring Company, and MyBiotics Pharma today announced a multi-year strategic collaboration to develop live microbiota-based biotherapeutics to address bacterial vaginosis, a common vaginal infection among women of reproductive age linked to increased risk of miscarriage and complications for pregnancy and fertility. The collaboration is an important step forward in harnessing the power of the human microbiome in this area…

Evofem Launches Its First DTC Advertising Campaign to Accelerate Awareness of Phexxi, Its Non-Hormonal Birth Control Option for Women

Earlier today Evofem announced the launch of “Get Phexxi”, a national direct-to-consumer campaign aimed at broadening awareness of its non-hormonal, use-it-only-when-you-need-it birth control method, Phexxi Approved by the U.S. Food and Drug Administration (FDA) in May 2020, Phexxi is an innovative non-hormonal contraceptive method created for women.  With 21 million women in the U.S. at risk for pregnancy who are NOT using hormonal contraception, the company feels the time is…

Emme’s Amanda French: “In 2019, Femtech received just under $800 million in funding. That number could be in the billions this decade.”

In our “Starter Story” series we invite femtech founders to share their stories of how it all began. How did they come up with the idea? Where did they meet their cofounders and what was the hardest part of going from 0 to 1? In today’s Starter Story we get to share Emme’s founding story as told by co-founder Amanda French. Emme is…

Women’s Reproductive Health Startup Ava Announces FDA Clearance for Ava Fertility Tracker

Ava, a digital healthcare company focused on women’s reproductive health, announced today it has received FDA clearance for its Ava Fertility Tracker, making it the first and only FDA-cleared fertility tracking wearable.   A fertility tracking sensor bracelet and accompanying app, Ava Fertility Tracker is already the first and only wearable, machine learning device to aid women in ovulation prediction and facilitation of…

Twentyeight Health Expands to the U.S. West Coast and Launches Its Telemedicine Platform in California, Oregon, and Washington

Twentyeight Health, a digital health company offering affordable access and convenience for women’s sexual and reproductive healthcare, today announced an expansion across the West Coast. Starting today, Twentyeight Health is available to residents of California, Oregon, and Washington. “As Twentyeight Health continues to grow its geographic footprint, our team remains committed to giving women who are under- or uninsured an affordable and…

Birth Control Delivery Company Pandia Health Launches in Colorado

If there’s anything the last year and the global pandemic taught us, it’s that we need the products and services we use delivered in the safest and most convenient way possible. A birth control delivery and telemedicine company is launching in Colorado to make life easier and healthier for women. Pandia Health is the only women-founded, women-led, doctor-led birth control delivery company. Founded in…